| Schedule of changes in derivative liability |
The following presents changes in the derivative
liability:
| |
|
Year Ended |
|
Quarter Ended |
|
Quarter Ended |
| |
|
12/31/19 |
|
12/31/19 |
|
09/30/19 |
|
06/30/19 |
|
03/31/19 |
|
12/31/18 |
| Beginning Balance |
|
$ |
11,917,000 |
|
|
$ |
14,130,000 |
|
|
$ |
14,536,000 |
|
|
$ |
15,854,000 |
|
|
$ |
11,917,000 |
|
|
$ |
— |
|
| New contract / contract additions |
|
|
4,000,000 |
|
|
|
4,000,000 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
15,114,000 |
|
| (Gain) loss in fair value recognized in earnings |
|
|
8,850,000 |
|
|
|
6,637,000 |
|
|
|
(406,000 |
) |
|
|
(1,318,000 |
) |
|
|
3,937,000 |
|
|
|
(3,197,000 |
) |
| |
|
$ |
24,767,000 |
|
|
$ |
24,767,000 |
|
|
$ |
14,130,000 |
|
|
$ |
14,536,000 |
|
|
$ |
15,854,000 |
|
|
$ |
11,917,000 |
|
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following instruments are currently antidilutive
and have been excluded from the calculations of diluted income or loss per share at December 31, 2016, 2017, 2018 and 2019, as
follows:
| |
|
December 31, |
| |
|
2019 |
|
2018 |
|
2017 |
|
2016 |
| Convertible notes and accrued interest |
|
|
98,794,390 |
|
|
|
93,657,637 |
|
|
|
26,156,533 |
|
|
|
24,266,533 |
|
| Convertible preferred stock - Series B |
|
|
11,818,181 |
|
|
|
11,818,181 |
|
|
|
11,818,181 |
|
|
|
11,818,181 |
|
| Warrants |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,083,332 |
|
| Compensation-based stock options and warrants |
|
|
199,027,315 |
|
|
|
137,427,315 |
|
|
|
52,586,692 |
|
|
|
84,782,003 |
|
|